Quantification of dideoxycytidine in human plasma by gas chromatography/mass spectrometry.
A gas chromatographic/mass spectrometric procedure has been developed for the quantification in plasma of dideoxycytidine (DDC), a candidate anti-AIDS drug. The assay uses an extraction with ethyl acetate containing 10% methanol followed by three derivatization steps: (i) reaction with t-butyl dimethyl chlorosilane to silylate the 5'-hydroxyl group; (ii) pentafluorobenzoylation of the amino group with pentafluorobenzoyl chloride; (iii) methylation of the ring nitrogen adjacent to the amino group with diazomethane. The resulting derivative is quantified using stable isotope dilution, selective ion monitoring and methane negative chemical ionization mass spectrometry. Plasma concentrations of DDC were measured over a range of 2-200 ng ml-1 using 1 ml plasma for extraction.
Rubio
F R
FR
Department of Drug Metabolism, Hoffmann-La Roche Inc, Nutley, New Jersey 07110.
Crews
T
T
Garland
W A
WA
Fukuda
E K
EK
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy; D015224:Dideoxynucleosides / Q000097:blood* / Q000627:therapeutic use; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D016047:Zalcitabine
D015224:Dideoxynucleosides; D016047:Zalcitabine